In a groundbreaking study conducted by the University at Buffalo, researchers have unveiled a potential link between the use of proton pump inhibitors (PPIs) and a reduced severity of gum disease. This discovery may pave the way for innovative approaches to managing periodontitis, a common and often debilitating oral health condition. In this article, we delve into the findings of this study and explore the implications it holds for individuals suffering from gum disease.

Proton pump inhibitor (ppi)-based medications for heartburn unexpectedly exhibited an effect in the treatment of gum diseases.

Understanding Gum Disease

Gum disease, clinically known as periodontitis, is a prevalent oral health issue characterized by inflammation, bone loss, and gum recession. It arises due to the presence of harmful bacteria that lead to an increased gap between the teeth and gums, known as probing depths. Periodontitis can result in tooth loss if left untreated, making it a critical concern for dental professionals and patients alike.

Proton pump inhibitor (ppi)-based medications for heartburn unexpectedly exhibited an effect in the treatment of gum diseases.

The Role of Proton Pump Inhibitors (PPIs)

Proton pump inhibitors are a class of drugs commonly prescribed to manage conditions such as heartburn, acid reflux, and ulcers. They work by reducing the production of stomach acid, thereby alleviating the symptoms associated with these conditions. However, recent research suggests that PPIs may have a previously unrecognized benefit – a potential reduction in the severity of gum disease.

The University at Buffalo Study

In a meticulous study led by Dr. Lisa M. Yerke and her team at the University at Buffalo School of Dental Medicine, over 1,000 periodontitis patients were analyzed to determine the relationship between PPI use and gum disease severity. The key indicator examined was probing depths, a critical measure of periodontitis severity.

The findings were remarkable. Patients who used PPIs exhibited smaller probing depths in their gums compared to those who did not use these medications. Specifically, only 14% of teeth from PPI users had probing depths of 6 millimeters or more, in contrast to 24% of teeth in non-PPI users. Furthermore, 27% of teeth from PPI users had probing depths of 5 millimeters or more, compared to a higher rate of 40% in non-PPI users.

The Mechanism Behind PPIs and Gum Disease

The researchers theorize that PPIs may influence gum disease severity through several potential mechanisms. Firstly, these medications are known to alter bone metabolism, which could contribute to the reduced probing depths observed in the study. Secondly, PPIs may impact the gut microbiome, which plays a crucial role in overall health, including oral health. Finally, it is possible that PPIs could affect periodontal microorganisms, potentially reducing their harmful effects.

Implications for Gum Disease Management

The implications of this study are significant. If PPIs are indeed found to have a positive impact on gum disease severity, it could open up new avenues for treatment and management. Combining PPIs with existing periodontal treatments could potentially enhance their effectiveness. However, it’s important to note that further research is needed to fully understand the underlying mechanisms and to determine the extent to which the relationship can be attributed directly to PPIs.


In conclusion, the University at Buffalo study offers a glimmer of hope for individuals suffering from gum disease. The potential link between PPI use and reduced gum disease severity is a promising avenue for future research and treatment strategies. If you or a loved one are dealing with gum disease, it’s essential to consult with a dental professional to explore all available options. While we await further research, the findings of this study may be a game-changer in the world of periodontal health.

Stay informed and consult with your dental professional to stay up-to-date on the latest developments in gum disease management. Your oral health is our priority, and together, we can work towards healthier smiles.


  1. Science Daily – Heartburn drugs may have unexpected benefits on gum disease – October 13, 2021

Wiley online Library – Association between proton pump inhibitors and periodontal disease severity 21 september 2021

uniqa banner
Curatorial Yurij
Curatorial Yurij
Head of Content at Uniqa Dental As an expert in dental industry, my task is to tell in a simple and fascinating way about complex highly organized series of procedures for the benefit of practitioners.